2seventy bio Inc.

NASDAQ: TSVT · Real-Time Price · USD
5.00
0.00 (0.00%)
At close: May 12, 2025, 3:59 PM

2seventy bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
48.37M 37.86M 45.62M 44.12M 71.2M 100.39M 145.88M 147.25M 124.69M 91.5M 51.35M 57.2M 51.05M 54.52M 48.39M 47.57M 150.13M
Cost of Revenue
23.22M 24.67M 22M 21.2M 22.26M 19.95M 29.1M 24.51M 24.65M 26.22M 11.3M 11.24M 16.75M 12.59M 13.68M 14.68M 83.48M
Gross Profit
25.15M 13.19M 23.62M 22.93M 48.94M 80.44M 116.78M 122.74M 100.04M 65.28M 40.05M 45.96M 34.3M 41.93M 34.71M 32.89M 66.65M
Operating Income
-60.08M -106.22M -142.83M -206.86M -234.49M -237.48M -204.76M -195.11M -224.01M -262.91M -304.12M -301.04M -312.12M -313.95M -327.12M -338.3M -242.82M
Interest Income
10.34M 10.88M 11.89M 12.66M 13.22M 12.41M 10.26M 7.74M 4.87M 2.93M 1.53M 416K 203K 88K n/a n/a n/a
Pretax Income
-4.09M -57.25M -94.55M -156.25M -223.22M -217.57M -183.91M -180.15M -215.46M -254.15M -291.97M -284.09M -290.73M -292.21M -308.04M -320.11M -221.69M
Net Income
-4.09M -57.25M -94.55M -156.25M -223.22M -213.02M -179.34M -175.15M -210.48M -248.93M -286.76M -279.32M -285.95M -292.21M -308.04M -320.11M -221.69M
Selling & General & Admin
46.11M 43.92M 51.6M 51.72M 61.35M 69.41M 71.91M 78.52M 76.31M 79.45M 85.23M 88.61M 92.74M 93.5M 90.97M 90.08M 92.1M
Research & Development
38.38M 74.81M 114.34M 157.34M 201.31M 227.73M 228.85M 239.28M 247.74M 248.74M 258.97M 258.36M 253.61M 261.94M 271.28M 282.4M 296.37M
Other Expenses
732K 675K -31K -534K -534K -534K n/a -624K -1.27M -1.27M -1.27M -644K n/a n/a n/a n/a n/a
Operating Expenses
83.56M 117.73M 164.77M 207.38M 262.66M 297.14M 300.77M 317.8M 324.05M 328.19M 344.2M 346.97M 346.35M 355.44M 362.25M 372.48M 303.94M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
108.45M 144.08M 188.45M 230.25M 284.92M 317.09M 329.86M 342.31M 348.7M 354.4M 355.5M 358.22M 363.1M 368.03M 375.93M 387.16M 387.42M
Income Tax Expense
n/a n/a n/a 17.1M 17.1M 12.55M 12.54M -5M -4.99M -5.22M -8.85M -8.36M -8.33M -3.18M 464K -412K -459K
Shares Outstanding (Basic)
53.05M 52.33M 52.26M 52.19M 52.07M 51.38M 51.18M 50.97M 43.47M 38.68M 38.57M 38.38M 26.75M 23.59M 23.29M 23.29M 23.29M
Shares Outstanding (Diluted)
53.43M 52.33M 52.26M 55.01M 52.07M 51.38M 51.18M 50.97M 43.47M 38.68M 38.57M 38.38M 26.75M 23.88M 23.29M 23.29M 23.29M
EPS (Basic)
-0.07 -1.09 -1.83 -3.04 -4.35 -4.32 -3.81 -4.16 -5.35 -7.4 -9.39 -10.22 -11.81 -12.52 -13.23 -13.75 -9.52
EPS (Diluted)
-0.1 -1.12 -1.86 -3.07 -4.35 -4.32 -3.81 -4.16 -5.35 -7.4 -9.35 -10.18 -11.77 -12.48 -13.23 -13.75 -9.52
EBITDA
-52.72M -98.45M -133.86M -176.56M -203.58M -206.42M -174.4M -185.86M -213.75M -251.38M -291.4M -285.98M -295.85M -297.16M -312.38M -325.76M -231.53M
EBIT
-59.35M -105.54M -142.33M -186.13M -213.72M -216.7M -183.98M -195.06M -224.01M -262.91M -304.14M -301.01M -312.05M -313.51M -303.01M -315.06M -219.63M
Depreciation & Amortization
6.63M 7.1M 8.47M 9.57M 10.14M 10.29M 9.58M 9.2M 10.26M 11.53M 12.74M 15.03M 16.2M 16.35M 16.13M 14.8M 13.6M